Artelo Biosciences (ARTL) Total Current Liabilities (2015 - 2025)
Artelo Biosciences (ARTL) posted quarterly Total Current Liabilities of $4.0 million for Q4 2025, up 128.22% year-over-year from $1.8 million in Q4 2024, and down 16.79% quarter-over-quarter from $4.9 million in Q3 2025.
Artelo Biosciences (ARTL) Total Current Liabilities (2015 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Total Current Liabilities for 11 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 128.22% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 128.22% YoY), while the FY2025 annual figure was $4.0 million, up 128.22% from the prior year.
- Total Current Liabilities slipped to $4.0 million in Q4 2025 per ARTL's latest filing, from $4.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $5.7 million in Q2 2025 and bottomed at $423943.0 in Q2 2021.
- Historically, Total Current Liabilities has averaged $1.5 million across 5 years, with a median of $850000.0 in 2022.
- Annual changes were most pronounced in 2024 — Total Current Liabilities dropped 24.32% — and 2025, when it jumped 597.27%.
- Artelo Biosciences' Total Current Liabilities stood at $659000.0 in 2021, then soared by 51.44% to $998000.0 in 2022, then grew by 29.36% to $1.3 million in 2023, then jumped by 37.26% to $1.8 million in 2024, then soared by 128.22% to $4.0 million in 2025.
- Business Quant data shows ARTL's Total Current Liabilities at $4.0 million in Q4 2025, $4.9 million in Q3 2025, and $5.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 630.93 Mn |
| 10 | Artelo Biosciences | 113,758.27 | -486,241.73 | - | 4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 697,000.00 |
| Jun 30, 2024 | 940,000.00 |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 921,000.00 |
| Jun 30, 2023 | 603,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 998,000.00 |
| Sep 30, 2022 | 480,000.00 |
| Jun 30, 2022 | 527,000.00 |
| Mar 31, 2022 | 875,000.00 |
| Nov 30, 2021 | 659,000.00 |
| Aug 31, 2021 | 526,000.00 |
| May 31, 2021 | 423,943.00 |
| Feb 28, 2021 | 588,966.00 |